Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3,703.41% | 198.76% | -234.61% | 24.96% | 184.27% |
| Total Depreciation and Amortization | -40.37% | -41.98% | -21.66% | -22.32% | -17.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,510.75% | -1,349.69% | -105.09% | -96.27% | -43.55% |
| Change in Net Operating Assets | -810.58% | 193.10% | 53.30% | 172.34% | 109.33% |
| Cash from Operations | -205.75% | -642.40% | -327.67% | 195.35% | 163.16% |
| Capital Expenditure | -12.82% | 9.78% | -- | 62.27% | 90.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71,782.05% | 30,716.30% | -- | 62.27% | 90.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -477.64% | -498.73% | -270.66% | 4.30% | -6.42% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -226.38% | -244.92% | -15.56% | 4.30% | -6.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 571.54% | 10,884.75% | -437.30% | 175.01% | 149.52% |